Edges in Network
| Network | GSE25065_egf1520 - GSE25065 - SiGN-BN HC+Bootstrap |
| Network Description | Validation cohort for genomic predictor of response and survival following neoadjuvant taxane-anthracycline chemotherapy in breast cancer |
| Node | CYP2U1 |
| Upstream (Parents) |
|---|
| (<<) ADRBK1 → CYP2U1 |
| (<<) AIFM1 → CYP2U1 |
| (<<) ATP10B → CYP2U1 |
| (<<) BMP8B → CYP2U1 |
| (<<) CDK5 → CYP2U1 |
| (<<) CPD → CYP2U1 |
| (<<) CSGALNACT2 → CYP2U1 |
| (<<) EIF6 → CYP2U1 |
| (<<) FGFBP1 → CYP2U1 |
| (<<) HK1 → CYP2U1 |
| (<<) HSP90AB1 → CYP2U1 |
| (<<) INF2 → CYP2U1 |
| (<<) KLK5 → CYP2U1 |
| (<<) LYPLA2 → CYP2U1 |
| (<<) MAPK14 → CYP2U1 |
| (<<) MTMR6 → CYP2U1 |
| (<<) NDRG1 → CYP2U1 |
| (<<) PLCD1 → CYP2U1 |
| (<<) PRKCG → CYP2U1 |
| (<<) RTN3 → CYP2U1 |
| (<<) SAA4 → CYP2U1 |
| (<<) SEPW1 → CYP2U1 |
| (<<) SGCA → CYP2U1 |
| (<<) SOCS3 → CYP2U1 |
| (<<) SPATA2L → CYP2U1 |
| (<<) STAM2 → CYP2U1 |
| (<<) STK4 → CYP2U1 |
| (<<) SYNJ2 → CYP2U1 |
| (<<) TMC7 → CYP2U1 |
| (<<) TP53 → CYP2U1 |
| (<<) TRAF1 → CYP2U1 |
| (<<) UBE2D2 → CYP2U1 |
| (<<) UBE2I → CYP2U1 |
| (<<) ZFP36 → CYP2U1 |
| Downstream (Children) |
|---|
| CYP2U1 → DYNC1LI2 (>>) |
| CYP2U1 → EPHA1 (>>) |
| CYP2U1 → EPHB6 (>>) |
| CYP2U1 → FER1L4 (>>) |
| CYP2U1 → MAPK8 (>>) |
| CYP2U1 → RDH16 (>>) |
| CYP2U1 → SEMA3A (>>) |
| CYP2U1 → SMAD1 (>>) |
